Makhosazane Majola

Makhosazane Majola currently serves as Business Director Market Access at Gilead Sciences, starting in April 2024, where responsibilities include developing commercial strategies for revenue growth in the Public Sector and mentoring a team in health economic modeling and market access. Previously, Majola was Business Unit Director at Organon, overseeing a budget of ZAR600 million and managing a staff of four until November 2025. At MSD South Africa from 2009 to 2020, Majola established a public sector division with significant contributions to overall revenues and aligned the organization with the National Health Insurance program. Additional experience includes roles at Novartis, National Medical Plan, University of KwaZulu-Natal, The University of Kansas, and Edendale Hospital. Majola's academic credentials encompass multiple degrees in business, economics, pharmacology, and pharmaco-economics from institutions including ZIGURAT Institute of Technology, Henley Business School, and Monash University.